TITLE

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity

AUTHOR(S)
Xianting Ding; Sanchez, David Jesse; Shahangian, Arash; Al-Shyoukh, Ibrahim; Genhong Cheng; Chih-Ming Ho
PUB. DATE
January 2012
SOURCE
International Journal of Nanomedicine;2012, Vol. 7, p2281
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82508970

 

Related Articles

  • Predicting the emergence of drug-resistant HSV-2: new predictions. Gershengorn, Hayley B.; Darby, Graham; Blower, Sally M. // BMC Infectious Diseases;2003, Vol. 3 Issue 1, p1 

    Background: Mathematical models can be used to predict the emergence and transmission of antiviral resistance. Previously it has been predicted that high usage of antivirals (in immunocompetent populations) to treat Herpes Simplex Virus type 2 (HSV-2) would only lead to fairly low levels of...

  • Anti-Herpetic Activity of Callissia fragrans and Simmondsia chinensis Leaf Extracts In Vitro. Yarmolinsky, Ludmila; Zaccai, Michele; Ben-Shabat, Shimon; Huleihel, Mahmoud // Open Virology Journal;2010, Vol. 4, p57 

    The antiviral activity of Callissia fragrans and Simnondsia chinensis aquatic and ethanol leaf extracts, as well as purified fractions from these extracts was studied against herpetic viruses in vitro. Ethanol extract of C. fragrans effectively inhibited the infection of Vero cells by HSV-1,...

  • 801. RNA Gene Therapy Targeting Herpes Simplex Virus. Jia Liu; Tuli, Sonal S.; Bloom, David C.; Schultz, Gregory S.; Ghivizzani, Steve C.; Lewin, Alfred S. // Molecular Therapy;Jun2006, Vol. 13, pS310 

    Purpose: Herpes Simplex Keratitis (HSK) is the leading cause of corneal blindness in developed nations. Despite active antiviral drugs (nucleoside analogues), there is no effective method preventing recurrent HSK. We tested the ability of ribozymes targeting the mRNAs of essential HSV genes to...

  • Treatment of Common Cutaneous Herpes Simplex Virus Infections. Emmert, Davis H. // American Family Physician;3/15/2000, Vol. 61 Issue 6, p1697 

    Presents information on antiviral drugs for herpes simplex virus (HSV). Diagnosis of genital HSV infection; Details on genital HSV; Information on orolabial herpes.

  • Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications. Chou, Timothy Y.; Hong, Bennett Y. // Therapeutics & Clinical Risk Management;2014, Vol. 10, p665 

    Eye disease due to herpes simplex virus (HSV) is a leading cause of ocular morbidity and the number one infectious cause of unilateral corneal blindness in the developed parts of the globe. Recurrent keratitis can result in progressive corneal scarring, thinning, and vascularization. Antiviral...

  • New Advances in Anti-HSV Chemotherapy. Superti, F.; Ammendolia, M. G.; Marchetti, M. // Current Medicinal Chemistry;2008, Vol. 15 Issue 9, p900 

    Treatment of human herpes simplex virus (HSV) diseases represents an important goal, as herpetic infections are not controlled by vaccination. Many therapeutic agents have been developed and used for HSV infections and several alternative natural compounds are under investigation. Most of the...

  • HSV therapy goes beyond antivirals. Scerra, Chet // Ophthalmology Times;9/1/2001, Vol. 26 Issue 17, p1 

    Discusses how to prevent recurrences of herpes simplex virus (HSV) without antiviral drugs. Prevalence of HSV; Effectiveness of acyclovir in reducing the recurrence of HSV; Information on cyclooxygenase (COX); Types of COX enzymes.

  • Herpes Simplex Viruses in Antiviral Drug Discovery. Schang, Luis M. // Current Pharmaceutical Design;Apr2006, Vol. 12 Issue 11, p1357 

    Since the 1950's, herpes simplex viruses (HSV) have played prominent roles in the development of antivirals. The first efficacious antivirals, as well as the first safe for systemic use, were developed against HSV. It was only in 1995 when the first antiviral against a target not validated first...

  • Acyclovir Therapy for the Orofacial and Ganglionic HSV Infection in Hairless Mice. PARK, NO-HEE; PAVAN-LANGSTON, DEBORAH; HETTINGER, MICHAEL E. // Journal of Dental Research;Dec1980, Vol. 59 Issue 12, p2080 

    Acyclovir (ACV) therapy, topical or systemic, showed a significantly high therapeutic efficacy for facial Herpes Simplex Virus (HSV) infection in hairless mice. When topical ACV treatment was initiated very early, i.e., three h post-inoculation, the number of mice with latent HSV infection in...

  • Modelling the cost per ulcer treated of incorporating episodic treatment for HSV-2 into the syndromic algorithm for genital ulcer disease. Vickerman, P.; Ndowa, F.; Mayaud, P. // Sexually Transmitted Infections;Jun2008, Vol. 84 Issue 3, p243 

    Background: The proportion of genital ulcer disease (GUD) due to herpes simplex virus type-2 (HSV-2) has increased in sub-Saharan Africa. The most recent 2003 WHO syndromic GUD algorithm includes antiviral treatment for HSV-2 for anyone with "typical" symptoms/signs, and suggests that all GUD...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics